Green Thumb Q2 Revenue Reaches $307M, Net Income $4.9M; Licensing Fees Squeeze Margins
GTBIF sits 37% above its 52-week low of $5.29.
Summary
Green Thumb reported Q2 revenue of $306.7 million, up 4.6% year-over-year, with net income of $4.9 million. Gross margins compressed to 45% due to RYTHM licensing fees, while the company continued aggressive share buybacks.
Key Events · Earnings and Guidance · GTBIF
-
Q2 Revenue Up 5% to $307M
Revenue reached $306.7 million, driven by retail growth in Minnesota and wholesale gains, but comparable sales fell 1.1% on a base of 103 stores.
-
Gross Margin Compressed to 45%
Gross profit was $137.9 million (45.0% of revenue), down from 49.9% a year ago, primarily due to $15.8 million in RYTHM brand licensing fees and price compression.
-
Net Income Swings to $4.9M Profit
GAAP net income was $4.9 million ($0.02/share) versus a $0.6 million loss last year, helped by lower income tax expense after cannabis rescheduling to Schedule III.
-
Aggressive Share Buybacks Continue
Repurchased 7.9 million Subordinate Voting Shares for $48.3 million at an average price of $6.11; $62.3 million remains under the buyback authorization through September 22, 2026.
Analysis · GTBIF · Industrial Applications And Services
Revenue grew 5% to $307 million, yet gross margin contracted to 45% from 50% a year ago, weighed down by RYTHM brand licensing fees and price compression. Net income swung to a modest $4.9 million profit from a small loss last year, aided by lower taxes following cannabis rescheduling. The company bought back 7.9 million shares for $48 million, signaling confidence, but the real story lies in margin erosion and rising SG&A costs — they reveal the price of retaining talent and paying for brand rights in a competitive market. With $284 million in cash and $283 million in debt, the balance sheet is solid, but investors will watch whether margin pressure persists.
At the time of this filing, GTBIF was trading at $7.27 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $5.29 to $10.43. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.